home / stock / vlon / vlon quote
Last: | $0.40 |
---|---|
Change Percent: | 8.7% |
Open: | $0.42 |
Close: | $0.40 |
High: | $0.4308 |
Low: | $0.3803 |
Volume: | 1,082,726 |
Last Trade Date Time: | 04/21/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.4 | $0.42 | $0.4 | $0.4308 | $0.3803 | 1,082,726 | 04-21-2023 |
$0.46 | $0.539 | $0.46 | $0.55 | $0.4333 | 1,228,299 | 04-20-2023 |
$0.539 | $0.4294 | $0.539 | $0.55 | $0.4201 | 2,800,897 | 04-19-2023 |
$0.425 | $0.42 | $0.425 | $0.4386 | $0.3916 | 902,776 | 04-18-2023 |
$0.4544 | $0.3622 | $0.4544 | $0.51 | $0.3622 | 1,698,041 | 04-17-2023 |
$0.362 | $0.3611 | $0.362 | $0.378 | $0.358 | 235,770 | 04-14-2023 |
$0.3701 | $0.38 | $0.3701 | $0.38 | $0.355 | 383,193 | 04-13-2023 |
$0.3996 | $0.41 | $0.3996 | $0.43 | $0.3733 | 545,192 | 04-12-2023 |
$0.4119 | $0.42 | $0.4119 | $0.43 | $0.3947 | 249,179 | 04-11-2023 |
$0.3971 | $0.3813 | $0.3971 | $0.4197 | $0.3813 | 280,453 | 04-10-2023 |
$0.3931 | $0.3659 | $0.3931 | $0.41 | $0.362 | 863,330 | 04-07-2023 |
$0.3931 | $0.3659 | $0.3931 | $0.41 | $0.362 | 863,330 | 04-06-2023 |
$0.44 | $0.36 | $0.44 | $0.5401 | $0.32 | 2,785,148 | 04-05-2023 |
$0.35 | $0.36 | $0.35 | $0.369 | $0.332 | 224,703 | 04-04-2023 |
$0.3503 | $0.36 | $0.3503 | $0.3737 | $0.35 | 175,526 | 04-03-2023 |
$0.3616 | $0.38 | $0.3616 | $0.39 | $0.35 | 255,123 | 03-31-2023 |
$0.3721 | $0.3756 | $0.3721 | $0.39 | $0.372 | 163,997 | 03-30-2023 |
$0.3756 | $0.37 | $0.3756 | $0.39 | $0.37 | 229,345 | 03-29-2023 |
$0.375 | $0.39 | $0.375 | $0.403859 | $0.3705 | 238,648 | 03-28-2023 |
$0.3968 | $0.395 | $0.3968 | $0.42 | $0.39 | 162,165 | 03-27-2023 |
News, Short Squeeze, Breakout and More Instantly...
Vallon Pharmaceuticals Inc. Company Name:
VLON Stock Symbol:
NASDAQ Market:
Combined company will operate as GRI Bio , Inc. and advance i nnovative p ipeline of Natural Killer T ( “ NKT ” ) modulating therapies for the treatment of i nflammatory, f ibrotic and a utoimmune d ...
Vallon’s b oard approves 1-for-30 r everse stock split Merger expected to close April 21, 2023 PHILADELPHIA, PA, April 20, 2023 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) (“Vallon” or the “Company”) toda...
Board of Directors unanimously recommend Vallon stockholders to vote “ FOR ” all proposals outlined in the Company’s definitive Proxy Statement (the “Proxy”) in order to close the proposed merger with GRI Bio , Inc. ...